Evidence map›Paper›PMID 39570865›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Increased Severity of Multidrug-Resistant Shigella sonnei Infections in People Experiencing Homelessness.

Aleksandra Stefanovic, Mosaab E Alam, Nancy Matic, Ashley Larnder, Gordon Ritchie, Leah Gowland, Samuel D Chorlton, Elisa Lloyd-Smith, Michael Payne, Meena Dawar and 6 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. New microbes and new infections · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. An Outbreak of Multidrug-ResistantTropical medicine and infectious disease · 2025
    Review
  9. Article
  10. AnalyzingInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Aleksandra StefanovicDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-9299-2040
Mosaab E AlamDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Nancy MaticDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-4158-6955
Ashley LarnderSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-2719-4613
Gordon RitchieDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Leah GowlandDivision of Medical Microbiology and Virology, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Samuel D ChorltonBugSeq Bioinformatics, Inc, Vancouver, British Columbia, Canada.ORCID 0000-0001-9891-8546
Elisa Lloyd-SmithSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Michael PayneDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0009-0002-3677-9776
Meena DawarSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Rohit VijhSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Victor LeungDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mark HullDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Kate S BakerDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-5850-1949
Christopher F LoweDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-9320-4499
Marc G RomneyDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShigella sonnei has caused sexually transmitted enteric infections in men who have sex with men (MSM) in Vancouver. We recently observed a high rate of multidrug-resistant (MDR) S. sonnei bacteremia among persons experiencing homelessness (PEH). We aimed to describe the wider epidemiology, clinical outcomes, and genomics of S. sonnei infections over time.

methodsA retrospective review of 163 patients with S. sonnei infections was undertaken from 2015 to 2022. We collected demographic, clinical, and microbiological data over 2 time periods: historical (2015-2020) and recent (2021-2022). Severe shigellosis definition included hospitalization, bacteremia, or death. Whole-genome sequencing was performed to identify genotype, infer relatedness, and predict antimicrobial resistance.

resultsS. sonnei infections increased from 8.3 (historical period) to 56.5 (recent period) cases/year. Over time, the primary population characteristics associated with shigellosis shifted from MSM (45; 98%) to PEH (86; 77%). The population intersection between MSM and PEH historically and recently was similar and occurred in 3 (6%) and 10 (9%) of patients, respectively. Severe shigellosis was significantly higher in the recent versus historical period (69 [61%] vs 7 [14%]; P < .001). A dominant clone of MDR S. sonnei, 3.6.1.1.2 (CipR.MSM5), emerged with resistance to all first- and second-line agents, yet with susceptibility to ceftriaxone.

conclusionsWe observed a substantial increase in severe shigellosis and shift from sexually transmitted S. sonnei infections in MSM to likely environmental transmission among PEH. More severe disease associated with the 3.6.1.1.2 clone of MDR S. sonnei in PEH could be a result of underlying vulnerabilities of the affected population.

Indexed as

Drug Resistance, Multiple, BacterialDysentery, BacillaryIll-Housed PersonsShigella sonneiAdultAgedAnti-Bacterial AgentsBacteremiaBritish ColumbiaFemaleHomosexuality, MaleHumansMaleMiddle AgedRetrospective StudiesWhole Genome SequencingAnti-Bacterial Agentsantimicrobial resistancepeople experiencing homelessnessseverityshigellosisS. sonnei

Identifiers

PMID39570865
PMCPMC11848260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.